The news for mesothelioma treatment continues reason for hope.  Drug researchers from China and the United States are working together on the KDR/Kit Inhibitor, which will work to end the new growth of cancerous cells in patients.

The two companies, China-based Simcere Pharmaceutical Group and OSI Pharmaceuticals in the U.S., are basing the project in China. OSI specializes in the discovery and development of innovative molecular targeted therapies. The drug, called OSI-930 for now, has shown positive results in treating small and non-small cell lung cancer, colorectal, gastric and other cancers. Its effectiveness in treating these cancers has the teams working on its treatment of mesothelioma as well.

The number of people dying from the asbestos-related disease mesothelioma has hit record levels and is not expected to peak until 2016, according to research from the Health and Safety Executive. Unfortunately New Jersey and Pennsylvania Residents will bear a disproportionate burden of the rise in mesothelioma as there were more asbestos factories in New Jersey and Pennsylvania combined than anywhere else in the country. As a result the mesothleioma rates in Pennsylvania and New Jersey are higher than most other places in the United States.

The good news is that the treatment options are improving and people are living longer. New options bring new hope for mesothelioma patients and their families.

Mesothelioma is a virulent form of cancer that is almost always caused by exposure to asbestos. The disease is usually fatal.

In 2007, the most recent year for which data is available, 2,156 death certificates cited mesothelioma as cause of death. This was up from 2,058 in 2006 and 2,046 the year before that.

HSE researchers have forecast an increase in the number of men suffering from mesothelioma year-on-year until 2016. The figures project a rise from 1,812 cases of mesothelioma among males this year to 2,016.

Projections are exclusively for mesothelioma cases among men because a decision was taken to divide the research project in two by sex. Estimates for female deaths will be published in due course. The ratio of male to female deaths in 2007 was around five-to-one.

A spokesperson for the HSE insisted that asbestos was not just a legacy problem. “Asbestos exposure is very much a present danger. A complete ban on asbestos was not introduced until 2000 and there are still 500,000 non-domestic premises in the country with asbestos. It is Britain’s biggest industrial killer.”

He added that asbestos awareness was a crucial issue not just for tradesmen, but for facilities managers too. “As well as education tradesmen who might be exposed to asbestos we need to educate the dutyholders who are responsible.”

The  ATSDR is a branch of the federal government charged with monitoring and providing information about dieases in the United States. Please click on the lnik below to access the ATSDR information on mesothelioma and asbestos. http://www.atsdr.cdc.gov/asbestos/living_asbestos/index.html